Latest News about Phase 3 Trial
Recent news which mentions Phase 3 Trial
AbbVie's Upadacitinib Hits Primary Goal In Induction Study In Patients With Crohn's Disease
December 06, 2021
Tickers
ABBV
From Benzinga
Biohaven's Zavegepant Pain Spray Aces Late-Stage Migraine Trial
December 06, 2021
Tickers
BHVN
From Benzinga
Why Did Aeglea BioTherapeutics Shares Nosedived To 52-Week Low On Monday Premarket?
December 06, 2021
Tickers
AGLE
From Benzinga
From Benzinga
Delcath Systems Reveals Initial Survival Data From Ocular Melanoma Trial
December 02, 2021
Tickers
DCTH
From Benzinga
RedHill Biopharma's Talicia For Bacterial Infections Shows Efficacy Irrespective of Patient BMI
December 02, 2021
Tickers
RDHL
From Benzinga
After FDA Rejection, Humanigen's COVID-19 Drug Hopeful Sees Some Light Of Good News
December 02, 2021
Tickers
HGEN
From Benzinga
Amgen's Otezla Meets Primary Goal In Late-Stage Genital Psoriasis Study
December 02, 2021
Tickers
AMGN
From Benzinga
Sage Therapeutics - Biogen Share One Year Zuranolone 50mg Data In Depression Patients
December 01, 2021
From Benzinga
Scholar Rock Outlines Pivotal Apitegromab Trial Design In Spinal Muscular Atrophy Patients
December 01, 2021
Tickers
SRRK
From Benzinga
Krystal Biotech Shares More Than Double During Premarket Monday: What Investors Need To Know
November 29, 2021
Tickers
KRYS
From Benzinga
Updated Data Shows Merck's Oral COVID-19 Antiviral Cuts Hospitalization, Death Risk By 30%
November 26, 2021
Tickers
MRK
From Benzinga
Takeda's Maribavir Scores FDA Approval For Post-Transplant CMV Infection
November 24, 2021
From Benzinga
Athenex To Present Subgroup Analysis Of Oral Paclitaxel-Encequidar Combo Data From Breast Cancer Trial
November 22, 2021
Tickers
ATNX
From Benzinga
Pfizer-BioNTech's COVID-19 Vaccine Shows 100% Effectiveness In Long Term Analysis In Adolescents
November 22, 2021
From Benzinga
AstraZeneca's COVID-19 Antibody Shows 83% Protection Over Six Months
November 18, 2021
From Benzinga
See Why Molecular Partners Shares Dropped To 52-Week Low During Tuesday Premarket?
November 16, 2021
From Benzinga
PhaseBio's Shares Slide As Antiplatelet Candidate Shows Higher Rates Of Side Effect
November 15, 2021
From Benzinga
GSK, Vir's Intramuscularly-Administered Sotrovimab Shows Efficacy At Par With IV Route In COVID-19
November 12, 2021
From Benzinga
Why Are Biogen Shares Gaining Today?
November 12, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
